Chewable DGL

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

Glycyrrhiza glabra, Quantity: 400 mg (Equivalent: Glycyrrhiza glabra, Qty 4 g)

Pieejams no:

Factors Group Australia Pty Ltd

Zāļu forma:

Tablet, chewable

Kompozīcija:

Excipient Ingredients: silicon dioxide; magnesium stearate; stearic acid; Aniseed Powder; microcrystalline cellulose; xylitol; Stevia rebaudiana

Ievadīšanas:

Oral

Ārstēšanas norādes:

Anti-inflammatory/relieve inflammation ; Demulcent/soothe irritated tissues ; Decrease/reduce/relieve abdominal pain/discomfort ; Decrease/reduce/relieve symptoms of heartburn ; Helps decrease/reduce/relieve mild gastrointestinal tract inflammation ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve throat mucous membrane irritation/inflammation

Produktu pārskats:

Visual Identification: ;

Autorizācija statuss:

Listed

Autorizācija datums:

2019-07-31